Rhoen-Klinikum AG ADS (RKAGY) Financials Oct 15, 2
Post# of 250675
Posted On: 11/17/2014 2:02:26 AM
Rhoen-Klinikum AG ADS (RKAGY) Financials Oct 15, 2014, 12:00 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Rhoen-Klinikum AG ADS
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.32B 2.55B 2.63B 2.86B 3.01B
Cost of Goods Sold (COGS) incl. D&A 2.08B 2.28B 2.38B 2.63B 2.75B
COGS excluding D&A 1.97B 2.17B 2.24B 2.49B 2.63B
Depreciation & Amortization Expense 101.8M 109.3M 141.5M 141.1M 119.7M
Depreciation 96.1M 102.2M 133.6M 133.2M 113.9M
Amortization of Intangibles 5.7M 7.1M 7.9M 7.9M 5.8M
Gross Income 243.84M 270.4M 246.9M 230.2M 262.1M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 190.3M 217.4M 218.9M 253M 281.3M
Research & Development - 0 0 - -
Other SG&A 190.3M 217.4M 218.9M 253M 281.3M
Other Operating Expense 27.18M 24.7M 26M 29.4M 35.4M
Unusual Expense 1.4M 200,000 - - -
EBIT after Unusual Expense (1.4M) (200,000) - - -
Non Operating Income/Expense 155.84M 167.3M 209.26M 204.6M 210.4M
Non-Operating Interest Income 4.83M 7.4M 8.8M 5.3M 2.3M
Equity in Affiliates (Pretax) 0 0 - 0 0
Interest Expense 26.92M 28.9M 33.6M 43.5M 40.4M
Gross Interest Expense 26.92M 28.9M 33.6M 43.5M 40.4M
Interest Capitalized 0 0 0 0 0
Pretax Income 158.71M 173.9M 186.46M 114.2M 117.7M
Income Tax 27.06M 28.8M 25.4M 21.8M 27.7M
Income Tax - Current Domestic 28.26M 29.8M 26.2M 21.9M 25.7M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (1.2M) (1M) (800,000) (100,000) 2M
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 40,000 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 131.65M 145.1M 161.1M 92.4M 90M
Minority Interest Expense 5.93M 5.4M 5M 2.3M 3.4M
Net Income 125.72M 139.7M 156.1M 90.1M 86.6M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 125.72M 139.7M 156.1M 90.1M 86.6M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 125.72M 139.7M 156.1M 90.1M 86.6M
EPS (Basic) 1.07 1.01 1.13 0.65 0.63
Basic Shares Outstanding 138.21M 138.21M 138.21M 138.21M 138.21M
EPS (Diluted) 1.07 1.01 1.13 0.65 0.63
Diluted Shares Outstanding 138.21M 138.21M 138.21M 138.21M 138.21M
EBITDA 128.16M 137.6M 143.5M 88.9M 65.1M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Rhoen-Klinikum AG ADS
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 2.32B 2.55B 2.63B 2.86B 3.01B
Cost of Goods Sold (COGS) incl. D&A 2.08B 2.28B 2.38B 2.63B 2.75B
COGS excluding D&A 1.97B 2.17B 2.24B 2.49B 2.63B
Depreciation & Amortization Expense 101.8M 109.3M 141.5M 141.1M 119.7M
Depreciation 96.1M 102.2M 133.6M 133.2M 113.9M
Amortization of Intangibles 5.7M 7.1M 7.9M 7.9M 5.8M
Gross Income 243.84M 270.4M 246.9M 230.2M 262.1M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 190.3M 217.4M 218.9M 253M 281.3M
Research & Development - 0 0 - -
Other SG&A 190.3M 217.4M 218.9M 253M 281.3M
Other Operating Expense 27.18M 24.7M 26M 29.4M 35.4M
Unusual Expense 1.4M 200,000 - - -
EBIT after Unusual Expense (1.4M) (200,000) - - -
Non Operating Income/Expense 155.84M 167.3M 209.26M 204.6M 210.4M
Non-Operating Interest Income 4.83M 7.4M 8.8M 5.3M 2.3M
Equity in Affiliates (Pretax) 0 0 - 0 0
Interest Expense 26.92M 28.9M 33.6M 43.5M 40.4M
Gross Interest Expense 26.92M 28.9M 33.6M 43.5M 40.4M
Interest Capitalized 0 0 0 0 0
Pretax Income 158.71M 173.9M 186.46M 114.2M 117.7M
Income Tax 27.06M 28.8M 25.4M 21.8M 27.7M
Income Tax - Current Domestic 28.26M 29.8M 26.2M 21.9M 25.7M
Income Tax - Current Foreign 0 0 0 0 0
Income Tax - Deferred Domestic (1.2M) (1M) (800,000) (100,000) 2M
Income Tax - Deferred Foreign 0 0 0 0 0
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 40,000 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 131.65M 145.1M 161.1M 92.4M 90M
Minority Interest Expense 5.93M 5.4M 5M 2.3M 3.4M
Net Income 125.72M 139.7M 156.1M 90.1M 86.6M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 125.72M 139.7M 156.1M 90.1M 86.6M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 125.72M 139.7M 156.1M 90.1M 86.6M
EPS (Basic) 1.07 1.01 1.13 0.65 0.63
Basic Shares Outstanding 138.21M 138.21M 138.21M 138.21M 138.21M
EPS (Diluted) 1.07 1.01 1.13 0.65 0.63
Diluted Shares Outstanding 138.21M 138.21M 138.21M 138.21M 138.21M
EBITDA 128.16M 137.6M 143.5M 88.9M 65.1M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)